Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

RapiOmics Assay Prototype Development

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

70792, MD, USA

Set-Aside

NONE

Documents

This scope was carved out of HT9426-26-NOI-045255.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

NOTICE OF INTENT TO SOLE SOURCE for the Development of a Handheld Device for Rapid Assessment of Burn Sepsis Risk

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs biochemical research and development for prime contractors on Walter Reed Army Institute of Research (WRAIR) projects. Develops a diagnostic assay capable of processing a single drop of blood and providing results within one hour using omics-based diagnostic reagents and microfluidic assay components. Must meet biotechnology R&D standards for performance specifications. Delivers a functional RapiOmics assay prototype.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
NIMH: Non-Competitive Combined Synopsis/Solicitati
Solicitation # 75N95B26Q00011
The National Institutes of Health Office of Logistics and Acquisition Operations is soliciting a Firm-Fixed Price Purchase Order under solicitation 75N95B26Q00011 for the procurement of one MBF Slice SL-100 Light Sheet Microscope system for the National Institute of Mental Health Section on Neuroanatomy. This equipment is intended for the direct 3D volumetric imaging of whole brains to research neuroanatomical circuits involved in motor behavior. The system must feature a high-resolution back-illuminated sCMOS camera, a motorized XYZ stage, and a specimen chamber compatible with various clearing methods such as CLARITY and iDISCO. Required hardware includes a high-performance PC workstation with a 32 inch 4K monitor, while required software includes MBF BrightSlice, NeuroInfo Studio BNS-250, and complimentary Neurolucida Explorer. Additionally, the contract requires a two year warranty and one year of image hosting and server management for Biolucida. This opportunity is designated as a small business set-aside with a response deadline of September 25, 2026. Award decisions will be based on the best value to the government, primarily considering price, with additional evaluations potentially including warranty, lifecycle cost, maintenance availability, and energy efficiency. Offerors must be registered in the System for Award Management and provide their Unique Entity Identifier, Taxpayer Identification Number, and business size certification. Delivery is to be made to Bethesda, Maryland, and respondents must specify their delivery period and FOB point. All submissions must be processed through the SAM.gov webportal.
National Institutes Of Health Olao

POSTED

about 24 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
ARPA-H Comprehensive Organ System Modeling in Outer Space (COSMOS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-165
The Advanced Research Projects Agency for Health (ARPA-H) has issued solicitation ARPA-H-SOL-26-165 for the Comprehensive Organ System Modeling in Outer Space (COSMOS) initiative. This program seeks to determine if microgravity in Low Earth Orbit (LEO) accelerates tissue aging in the brain, heart, uterus, and kidney across specific adult age brackets. If the Tissue Aging Rate in Space (TARIS) is proven to exceed the rate on Earth, the initiative aims to establish a high-throughput, autonomous drug screening platform in LEO that is more cost-effective and faster than terrestrial research and development. The government intends to award multiple Other Transaction (OT) Agreements to a diverse range of eligible entities, including universities, non-profits, and businesses of all sizes. The project is structured into two sequential phases: Phase I lasts 27 months, focusing on development and testing, while Phase II lasts 15 months and includes two planned space launches. Key deliverables include the quantification of TARIS using microphysiological systems (MPS), the creation of a licensable dataset of terrestrial and LEO twin data, and the establishment of a public-private partnership with a Fortune 100 pharmaceutical company. Technical requirements are stringent, requiring that at least 75 percent of experimental samples be MPS and that donor age brackets be strictly maintained at 30, 45, and 60 years (plus or minus 2 years). Proposals are evaluated based on technical innovation, risk mitigation, the potential to transform biomedicine, and commercial application viability. The government utilizes a milestone-based payment system where funding is tied to the achievement of quantitative exit criteria. Applicants must provide a comprehensive submission including a technical and management proposal, a task description document, a cost proposal, and certifications regarding eligibility and national policy compliance, including research security and cybersecurity standards.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

2 days ago

DEADLINE

in 18 days
View Details
NAICS: 541714
New
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Solicitation # ARPA-H-SOL-26-162
The Advanced Research Projects Agency for Health (ARPA-H) has issued Innovative Solutions Opening (ISO) ARPA-H-SOL-26-162 for the UNifying Imaging with QUantum Entanglement (UNIQUE) Program. This merit-based solicitation seeks to develop new biomedical imaging capabilities by exploring quantum-derived observables, such as photon correlation signatures and positronium-sensitive interactions, to reveal biological information invisible to current imaging technologies. The agency anticipates awarding multiple Other Transaction (OT) Agreements to proposers who can demonstrate highly innovative and feasible technical approaches. The submission process is divided into two stages, with solution summaries due October 30, 2026, and full proposals due by December 15, 2026. Full proposals must be submitted via the ARPA-H Solutions portal in three volumes: Technical and Management, Cost, and Administrative and Policy Requirements. Evaluation is based on technical innovation and feasibility, proposer capabilities, relevance to the ARPA-H mission, and cost. For-profit organizations that are not small businesses under NAICS 541714 are required to provide a meaningful cost share. Strict compliance is required regarding research security, including disclosures of foreign influence and prohibitions on participation in Malign Foreign Talent Recruitment Programs. Additionally, the program excludes proposals that offer only incremental improvements or utilize human embryos or fetal tissue. Awardees will be expected to provide monthly status reports and participate in semi-annual in-person review meetings, with all key personnel expected to be onboard within 60 days of the award.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

3 days ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Federal
Firefox
Solicitation # DARPA-PS-26-137
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office has issued solicitation DARPA-PS-26-137 for the Firefox program, which aims to develop a 100-channel, non-invasive brain-computer interface (BCI) featuring 50-micron spatial and 100-microsecond temporal resolution. The program is divided into two primary technical areas: the development of components for dynamic rastering and scanning of coherent optical signals to target multiple regions of interest, and the creation of data processing architectures beyond the digital domain to manage high data rates and computational burdens. This 36-month effort is structured across three phases, with anticipated funding for multiple awards ranging between 4 million and 7 million dollars. The procurement is conducted as an Other Transaction for Prototype, utilizing a model agreement rather than standard FAR clauses, though it requires CMMC Level 1 self-assessment for safeguarding federal contract information. The selection process is based on a two-step submission: an initial abstract due October 19, 2026, followed by an invitation to submit an Oral Presentation Proposal (OPP) package by November 9, 2026. Proposals are evaluated as selectable or non-selectable based on the innovation and feasibility of the technical approach, relevant qualifications of the personnel, and the practicality of the budget. Performance is measured against specific technical metrics, such as a 10 ms full volume scan rate in Phase 2, with payments tied to a 16-milestone schedule and processed via the Wide Area Workflow system.
Defense Advanced Research Projects Agcy

POSTED

3 days ago

DEADLINE

in about 2 months
View Details
NAICS: 541714
New
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Solicitation # ARPA-H-SN-26-162
The Advanced Research Projects Agency for Health (ARPA-H), through its Health Science Futures Office, has issued Special Notice ARPA-H-SN-26-162 to announce the UNifying Imaging with QUantum Entanglement (UNIQUE) program. This initiative aims to establish a new biomedical imaging paradigm by utilizing quantum-derived observables, specifically entangled or quantum-correlated 511 keV photon pairs, to reveal disease biology that is currently invisible to existing technologies. The program is divided into two primary technical areas: the Imaging Core, which focuses on the physical systems and detectors required to generate and measure quantum-derived imaging contrast, and Quantum AI Interpretation and Fusion, which focuses on developing AI-driven reconstruction methods to integrate these observables into multidimensional imaging representations. This special notice serves as an informational alert and does not constitute a formal solicitation. It announces a hybrid Proposers Day scheduled for October 15, 2026, to prepare the scientific community for an upcoming Innovative Solutions Opening (ISO) expected by September 18, 2026. Interested parties are encouraged to submit a single capability slide via the UNIQUE Teaming Profile Form by September 22, 2026, to participate in lightning talks during the event. Technical inquiries are directed to Program Manager Wilfred Ngwa at UNIQUE@arpa-h.gov.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

3 days ago

DEADLINE

in 24 days
View Details
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.
NASA Johnson Space Center

POSTED

3 days ago

DEADLINE

in 12 days
View Details

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS